Nobel Prize Recognizes Groundbreaking Body's Defenses Research

The prestigious award in medical science has been awarded for transformative discoveries that illuminate how the body's defense network attacks harmful infections while sparing the healthy tissues.

Three esteemed scientists—Japan's Shimon Sakaguchi and American experts Mary Brunkow and Fred Ramsdell—received this accolade.

Their work uncovered unique "sentinels" within the immune system that eliminate malfunctioning defense cells that could attacking the organism.

These findings are now enabling new therapies for immune disorders and cancer.

These winners will divide a monetary award worth 11m SEK.

Crucial Discoveries

"Their work has been decisive for understanding how the immune system operates and why we do not all develop serious self-attack conditions," stated the head of the award panel.

The team's research explain a core question: In what way does the immune system defend us from numerous invaders while leaving our own tissues unharmed?

Our immune system uses immune cells that search for indicators of disease, including viruses and bacteria it has not met before.

These cells utilize sensors—known as recognition units—that are produced by chance in countless combinations.

This gives the immune system the ability to fight a broad range of threats, but the unpredictability of the process inevitably creates white blood cells that can target the body.

Protectors of the Body

Scientists previously understood that some of these harmful white blood cells were eliminated in the immune organ—the site where white blood cells develop.

The latest award honors the discovery of T-reg cells—described as the immune system's "peacekeepers"—which patrol the body to neutralize other immune cells that assault the healthy cells.

We know that this mechanism fails in autoimmune diseases such as juvenile diabetes, multiple sclerosis, and rheumatoid arthritis.

A prize committee added, "These discoveries have laid the foundation for a novel area of research and accelerated the development of innovative treatments, for example for cancer and immune disorders."

In malignancies, regulatory T-cells block the body from attacking the tumor, so research are aimed at lowering their numbers.

In self-attack disorders, experiments are testing increasing T-reg cells so the body is no longer being harmed. A comparable approach could also be useful in minimizing the risks of transplanted organ failure.

Innovative Experiments

Professor Sakaguchi, from a Japanese institution, performed tests on mice that had their thymus removed, leading to self-attack conditions.

He showed that introducing immune cells from healthy mice could prevent the disease—suggesting there was a mechanism for preventing immune cells from attacking the host.

Mary Brunkow, affiliated with the a research center in a US city, and Fred Ramsdell, now at Sonoma Biotherapeutics in San Francisco, were investigating an genetic autoimmune disease in mice and humans that resulted in the identification of a gene vital for how regulatory T-cells function.

"The pioneering research has revealed how the immune system is kept in check by regulatory T cells, preventing it from accidentally attacking the body's own tissues," commented a prominent physiology specialist.

"This work is a remarkable example of how fundamental biological study can have far-reaching implications for human health."